S. Chikkali, S. Magens, D. Gudat, M. Nieger, I. Hartenbach, T. Schleid
H 4.18; found C 61.2, H 4.68. H NMR (CDCl3): δ = 7.8–7.3 (m, Reaction of 6 with dabco: The donor dabco (16 mg, 0.14 mmol) was
FULL PAPER
1
2
C6H5), 7.1–6.7 (m, C6H3), 4.3 (d, JPH = 11.5 Hz, CH2 of cis iso-
mer), 4.2 (t, ΣJPH = 7.8 Hz, CH2 of trans isomer) ppm. 13C{1H}
NMR (CDCl3, only data of trans isomer given): δ = 147.9 (t, ΣJCP
added to a solution of 6 (70 mg, 0.07 mmol) in thf (6 mL). The
resulting mixture was stirred for 1 h during which a yellow precipi-
tate was formed. The volatiles were evaporated under reduced pres-
= 5.0 Hz, C6H3), 147.7 (t, JPC = 1.2 Hz, C6H3), 135.0 (s, Ph), 133.9 sure. The residue was suspended in thf (5 mL), and diethyl ether
3
(t, JPC = 6 Hz, m-C), 132.2 (s, Ph), 130.8 (s, Ph), 128.0 (s, Ph), (20 mL) was added. The supernatant liquid was decanted off, and
127.9 (t, JPC = 5 Hz, i-C), 125.3 (br., B–C), 124.8 (t, JPC = 2.4 Hz,
C6H3), 122.4 (s, C6H3), 119.0 (t, JPC = 2.0 Hz, C6H3), 110.8 (t, JPC
the remaining precipitate dried in vacuo to give 56 mg of a yellow–
orange powder. M.p. 167 °C. C50H40B2Cl2O4P2Pd·1.2dabco: calcd.
C 62.44, H 4.98, N 3.05; found C 61.39, H 5.14, N 2.92. 11B MAS
1
= 1.6 Hz, C6H3), 25.0 (t, JPC = 13 Hz, CH2) ppm. 31P{1H} NMR
(CDCl3): δ = 30.6 (cis isomer), 20.4 (trans isomer) ppm. 11B NMR NMR (solid): δiso = 5 ppm. 31P{1H} CP/MAS NMR (solid): see
(CDCl3): δ = 29.1 (br.) ppm.
Figure 4 bottom.
Palladium Bis[diphenyl-(2,3-dihydroxyphenylmethyl)phosphane] Di-
chloride (7): To a solution of 1 (200 mg, 0.64 mmol) in thf (20 mL)
was added (cod)PdCl2 (93 mg, 0.32 mmol). The reaction mixture
was stirred for 2 h at room temperature and then concentrated un-
der reduced pressure to half the total volume. Shiny yellow needle-
like crystals were obtained on stirring this solution overnight at
+4 °C. The crystals were isolated by filtration and dried in vacuo.
Yield: 240 mg (95%). M.p. 176 °C. C38H34Cl2O4P2Pd·thf (866.07):
calcd. C 58.25, H 4.89; found C 58.06, H 5.27. 1H NMR (CD3CN):
[PdCl2(8a)2]: (cod)PdCl2 (110 mg, 0.39 mmol) was added to a
stirred solution of 8a (400 mg, 0.78 mmol) in thf (20 mL). A yellow
precipitate began to separate after 5 min, and stirring was contin-
ued for 1 h. Diethyl ether (40 mL) was then added, and the yellow
precipitate was filtered off. Drying in vacuo for 3 h gave 352 mg
(yield 75%) of product. M.p. 191 °C. C64H60B2Cl2N4O4P2Pd
(1210.10): calcd. C 63.53, H 5.00, N 4.63; found C 63.00, H 4.92,
N 4.64. 11B MAS- and 31P{1H} CP/MAS-NMR spectra are dis-
played in Figure 4 top and middle. The solution NMR spectra of
freshly prepared samples showed signals attributable to a mixture
of cis/trans isomers of [PdCl2(8a)2] [11B NMR: δ = 10.6 ppm;
31P(1H) NMR: δ = 37.9 (cis isomer), 18.4 (trans isomer) ppm] in
addition to signals for decomposition products. The intensity of
the signal for the decomposition products increased upon standing.
2
δ = 7.8–7.1 (m, Ph), 7.0–7.65 (m, C6H3), 4.23 (d, JPH = 11.6 Hz,
CH2 of cis isomer), 4.13 (t, Σ2JPH = 8.0 Hz, CH2 of trans isomer);
3.77 (m, 4 H, thf), 1.93 (m, 4 H, thf) ppm. 13C{1H} NMR (CD3CN,
only data of trans isomer given): δ = 145.3 (t, ΣJCP = 2.1 Hz, C6H3),
144.6 (t, ΣJCP = 5.8 Hz, C6H3), 134.8 (t, JPC = 6.1 Hz, i-C), 131.7
(s, Ph), 130.3 (m, ΣJPC = 45.9 Hz, C6H3), 128.9 (t, ΣJPC = 10.2 Hz,
Ph), 123.8 (t, ΣJPC = 5.8 Hz, C6H3), 120.9 (t, ΣJPC = 2.6 Hz, C6H3),
120.4 (s, C6H3), 114.7 (t, ΣJCP = 2.8 Hz, C6H3), 68.3 (s, thf), 26.2 (s,
thf), 25.3 (t, JPC = 13.9 Hz, CH2) ppm. 31P{1H} NMR (CD3CN): δ
= 32.2 (cis isomer), 18.7 (trans isomer) ppm.
Crystal Structure Study: The single-crystal X-ray diffraction studies
of trans-6, trans-7 and 8a were carried out on a Bruker-Nonius
Kappa-CCD diffractometer at 123(2) K using Mo-Kα radiation (λ
= 0.71073 Å). Direct Methods (SHELXS-97[17]) were used for
structure solution, and full-matrix least-squares refinement on F2
(SHELXL-97[17]). H atoms were localised by difference Fourier
synthesis and refined by using a riding model.
Diphenyl-(2-phenylbenzo[1,3,2]dioxaborol-4-ylmethyl)phosphane-3-
(dimethylaminopyridine) (8a): The donor dmap (244 mg, 2 mmol)
was added to a solution of 3 (790 mg, 2 mmol) in CH2Cl2. The
reaction mixture was stirred for 1 h. Evaporation of the solvent
under reduced pressure and drying of the colourless residue in
vacuo gave 980 mg of 8a (yield 95%). M.p. 167 °C. C32H30BN2O2P
(516.39): calcd. C 74.43, H 5.86, N 5.43; found C 74.20, H 5.93, N
5.41. 1H NMR (CDCl3): δ = 8.25 (m, 2 H, dmap), 7.55–7.40 (m, 6
6: Yellow-orange crystals, C50H40B2Cl2O4P2Pd·2thf, M = 1109.89,
crystal size 0.20ϫ0.10ϫ0.05 mm, monoclinic, space group P21/c
(No. 14): a = 11.7333(7) Å, b = 22.9485(17) Å, c = 10.3897(5) Å, β
= 111.424(4) °, V = 2604.2(3) Å3, Z = 2, ρ(calcd.) = 1.415 Mgm–3,
F(000) = 1144, µ = 0.572 mm–1, 22106 reflections (2θmax = 50°),
4480 unique [Rint = 0.102], 322 parameters, 66 restraints, R1
[IϾ2σ(I)] = 0.048, wR2 (all data) = 0.088, GooF = 0.862, largest
diff. peak and hole 0.672 and –0.429 eÅ–3.
3
H, C6H5), 7.40–7.20 (m, 9 H, C6H5), 6.62 (ddd, JHH = 7.6 Hz,
4JHH = 1.3 Hz, JPH = 1.3 Hz, 1 H, C6H3), 6.50 (m, 2 H, dmap),
3
3
6.48 (dd, JHH = 7.6 Hz, 7.8 Hz, 1 H, C6H3), 6.39 (ddd, JHH
=
7.6 Hz, 4JHH = 1.3 Hz, JPH = 1.3 Hz, 1 H, C6H3), 3.5 (s, 2 H, CH2),
3.01 (s, 6 H, dmap) ppm. 31P{1H} NMR (CDCl3): δ = –17.2 ppm.
11B NMR (CDCl3): δ = 11.1 (br.) ppm.
7: Yellow–orange crystals, C38H34Cl2O4P2Pd·4thf, M = 1082.31,
crystal size 0.5ϫ0.3ϫ0.1 mm, monoclinic, space group P21: a =
10.2633(2) Å, b = 22.7369(4) Å, c = 11.6400(2) Å, β = 112.586(1)°,
V = 2507.93(8) Å3, Z = 2, ρ(calcd.) = 1.433 Mgm–3, F(000) = 1128,
µ = 0.595 mm–1, 42973 reflections (2θmax = 56.54°), 12092 unique
[Rint = 0.113, Rσ = 0.087], 749 parameters, 1 restraint to fix the
origin, flack parameter x = 0.51(2), therefore refined as inversion
twin, R1 [IϾ2σ(I)] = 0.053, wR2 (all data) = 0.126, GooF = 1.032,
largest diff. peak and hole 1.27 and –1.46 eÅ–3.
Diphenyl-(2-phenylbenzo[1,3,2]dioxaborol-4-ylmethyl)phosphane-3-
[1,4-azabicyclo(2.2.2)octane] (8b): The donor dabco (160 mg,
1.4 mmol) was added to a solution of 3 (550 mg, 1.4 mmol) in thf.
The reaction mixture was stirred for 1 h. Evaporation of the solvent
under reduced pressure and drying of the colourless residue
in vacuo gave 664 mg of 8b (yield 92%). M.p. 132 °C.
C31H32BN2O2P·thf (578.50): calcd. C 72.67, H 6.97, N 4.84; found
C 71.97, H 6.76, N 4.49. 1H NMR (CDCl3): δ = 7.66 (m, 2 H,
BC6H5), 7.48 (m, 4 H, PC6H5), 7.36–7.21 (m, 9 H, BC6H5, PC6H5),
8a: Colourless crystals, C32H30BN2O2P·thf, M = 588.46, crystal size
0.12ϫ0.06ϫ0.03 mm, monoclinic, space group P21/c (No. 14): a
= 14.7942(4) Å, b = 9.5746(4) Å, c = 22.8934(7) Å, β = 93.558(2) °,
V = 3236.57(19) Å3, Z = 4, ρ(calcd.) = 1.208 Mgm–3, F(000) =
1248, µ = 0.122 mm–1, 10492 reflexes (2θmax = 50°), 5703 unique
[Rint = 0.145], 390 parameters, 96 restraints, R1 [IϾ2σ(I)] = 0.120,
wR2 (all data) = 0.227, GooF = 1.103, largest diff. peak and hole
0.385 and –0.335 eÅ–3.
2
6.68–6.51 (m, 3 H, C6H3), 3.73 (m, thf), 3.51 (d, JPH = 1 Hz, 1 H,
CH2), 2.80 (s, 12 H, dabco), 1.83 (m, thf) ppm. 13C{1H} NMR
(CDCl3): δ = 150.9 (d, JPC = 1.7 Hz, C6H3), 149.6 (d, JPC = 4.3 Hz,
1
C6H3), 139.2 (d, JPC = 16 Hz, i-C), 133.5 (s, Ph), 133.0 (d, JPC
=
18.6 Hz, m-C), 128.4 (s, p-C), 128.3 (d, JPC = 6.4 Hz, o-C), 128.1
(s, Ph), 127.3 (s, Ph), 121.2 (d, JPC = 8.0 Hz, C6H3), 119.5 (d, JPC
= 9.2 Hz, C6H3), 119.3 (d, JPC = 1.5 Hz, C6H3), 107.7 (d, JPC
=
CCDC-672200 (6), CCDC-672366 (7), CCDC-672201 (8a) contain
2.5 Hz, C6H3), 44.8 (s, dabco), 28.8 (d, 1JPC = 14.8 Hz, CH2) ppm. the supplementary crystallographic data for this paper. These data
31P{1H} NMR (CDCl3): δ = –12.0 ppm. 11B NMR (CDCl3): δ = can be obtained free of charge from The Cambridge Crystallo-
14.9 (br.) ppm.
2212
graphic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
www.eurjic.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2008, 2207–2213